Submit Deal

STADA ARZNEIMITTEL AG

HQ - Bad Vilbel

Summary

Stada Arzneimittel manufactures pharmaceuticals. The Company produces generics (products whose patents have expired), brand-name products, and cancer therapy and other special pharmaceuticals. Stada avoids cost-intensive research on active ingredients and concentrates on multi-source products. The Company markets its products worldwide.

Deals Overview

Total Deals10

Valued Deals3

Total Value£ 4.96 B

Avg. Deal Size£ 1.65 B

Market Context

Senior Management

Peter Goldschmidt
Chairman and CEO
Mark Keatley
CFO
Miguel Pagan Fernandez
Chief Technology Officer

Sort

mark keatley

CFO at STADA ARZNEIMITTEL AG

Manager

Deals

£ 4.45 B

Total Value

miguel pagan fernandez

Chief Technology Officer at STADA ARZNEIMITTEL AG

Manager

Deals

£ 4.45 B

Total Value

borys labensky

General Manager at STADA ARZNEIMITTEL AG

Manager

Deal

n/a

Total Value

pavel burmistrov

Senior Project Manager Corporate Development at STADA ARZNEIMITTEL AG

Manager

Deal

n/a

Total Value

felix von berg

Corporate Development Director at STADA ARZNEIMITTEL AG

Manager

Deal

n/a

Total Value

steffen wagner

Head of European Markets at STADA ARZNEIMITTEL AG

Manager

Deals

n/a

Total Value

peter goldschmidt

Chairman and CEO at STADA ARZNEIMITTEL AG

Manager

Deals

£ 4.96 B

Total Value

stephan eder

Western Europe and Germany Head at STADA ARZNEIMITTEL AG

Manager

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy